Kestra, a trailblazer in patient-centered healthcare technologies, has successfully secured $200 million in funding to enhance its groundbreaking efforts in cardiac monitoring and patient care. Headquartered in Kirkland, Washington, and part of the esteemed Bain Capital portfolio, Kestra is driven by a mission to stand for at-risk patients and the dedicated caregivers who support them. With cardiovascular disease recognized as the leading global cause of death, Kestra is committed to transforming the landscape of cardiac health through innovative wearable technologies and applications that empower patients in their recovery journey. This funding will enable Kestra to further develop its advanced suite of wearable monitoring products, providing patients with vital insights about their health while simultaneously equipping medical professionals with the necessary tools to deliver immediate and effective care. By prioritizing comfort and assurance for patients facing challenging medical situations, Kestra aims to redefine the recovery process and make it more accessible and supportive. As the company accelerates its growth, the investment will bolster research and development efforts, expand its product offerings, and enhance partnerships within the medical community. This significant financial boost underscores the confidence investors have in Kestra’s vision and capability to deliver transformative solutions in the realm of cardiac health. To learn more about our initiatives and commitment to patients, visit us at www.kestramedical.com.








